SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark Pharmaceuticals board to consider Unaudited Financial Results

14 Jan 2014 Evaluate

Glenmark Pharmaceuticals has informed that a meeting of the Board of Directors of the company will be held on January 24, 2014, to consider and approve the Company Un-audited Financial Statements for the Third Quarter ended December 31, 2013.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2174.95 -6.50 (-0.30%)
05-Jun-2026 11:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1793.10
Dr. Reddys Lab 1277.05
Cipla 1388.60
Zydus Lifesciences 1090.10
Lupin 2272.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×